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Abstract
Purpose
To compare intraocular pressure (IOP) after trabectome-mediated ab interno trabecu-
lectomy surgery in phakic patients (T) and trabectome with same session phacoemulsifi-
cation (PT) using Coarsened Exact Matching. Although phacoemulsification is
associated with IOP reduction when performed on its own, it is not known how much it
contributes in PT.
Methods
Subjects were divided into phakic T and PT. Exclusion criteria were follow-up for <12
months and additional glaucoma surgery. Demographics were compared by the Mann-
Whitney U test and chi-squared test for continuous and categorical variables, respectively.
Multiple imputation was utilized to avoid eliminating data with missing values. Groups were
then matched using Coarsened Exact Matching based on age, race, type of glaucoma,
baseline IOP, and number of preoperative glaucoma medications. Univariate linear regres-
sion was used to examine IOP reduction after surgery; those variables that were statistically
significant were included in the final multivariate regression model.
Results
A total of 753 cases were included (T: 255, PT: 498). When all variables except for age
were kept constant, there was an additional IOP reduction of 0.05±0.01 mmHg conferred for
every yearly increment in age. Every 1 mmHg increase in baseline IOP correlated to an
additional IOP reduction of 0.80±0.02 mmHg. Phacoemulsification was not found to be a
statistically significant contributor to IOP when comparing T and PT (p0.05). T had a 21%
IOP reduction to 15.9±3.5 mmHg (p<0.01) while PT had an 18% reduction to 15.5±3.6
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mmHg (p<0.01). Number of medications decreased (p<0.01) in both groups from 2.4±1.2 to
1.9±1.3 and from 2.3±1.1 to 1.7±1.3, respectively.
Conclusion
Phacoemulsification does not make a significant contribution to postoperative IOP or num-
ber of medications when combined with trabectome surgery in phakic patients.
Introduction
Glaucoma and cataracts often coincide in the same individual, with elevated baseline IOP
resulting in a 2-fold increased odds of developing an incident nuclear cataract.[1] Although it
is not established whether a true causative relationship exists between the two, several studies
found that cataract surgery can lower intraocular pressure (IOP) by an average of 1.5–3 mmHg
and that a higher preoperative IOP correlates with a greater postoperative IOP reduction.[2–4]
Microincisional glaucoma surgeries (MIGS) can lower IOP on their own or in combination
with cataract surgery.[5] Both practice patterns are standardized, safe, and can also be more
cost-effective than topical medications.[6] The first studies of trabecular microbypass stents,
estimated to provide access outflow segments over approximately 60 degrees,[7] demonstrated
a significant IOP reduction that was similar in patients who had cataract surgery with same ses-
sion microbypass stent and the control group that only had phacoemulsification.[8] Ab interno
trabeculectomy with the trabectome uses plasma to ionize and remove up to 180 degrees of tra-
becular meshwork (TM).[5] Trabectome surgery alone or combined with phacoemulsification
seemed to achieve similar postoperative IOPs in a nonrandomized comparison.[9,10] We
recently applied matching to achieve a more balanced comparison of outcomes of trabectome
with same session cataract surgery to cataract surgery followed by trabectome surgery years
later and noted a small additive effect in IOP reduction of same session cataract removal.[11]
Although statistically significant, this additional IOP reduction of 0.73±0.32 mmHg from pha-
coemulsification may be of limited clinical relevance.[11]
In the current study, we hypothesized that a comparison of phacoemulsification combined
with trabectome surgery (PT) to trabectome (T) in eyes that remain phakic, might better isolate
an IOP reduction inferred by phacoemulsification. Such a comparison is difficult to conduct
without a sophisticated matching algorithm because of the inherently different demographics
of individuals requiring phacoemulsification versus those that do not yet have a cataract. To
precisely delineate whether same session cataract surgery had an additive IOP lowering effect
without introducing confounding variables, subjects with additional glaucoma surgery were
excluded. Here, we applied a recently introduced method, Coarsened Exact Matching (CEM),
[12] to test our hypothesis.
Methods
Participants
Data for this study were collected with approval by the Institutional Review Board of the Uni-
versity of Pittsburgh, in accordance with the Declaration of Helsinki and the Health Insurance
Portability and Accountability Act. No informed consent was necessary for this retrospective,
observational cohort study. Patient records were anonymized and de-identified prior to analy-
sis. Subjects were divided into phakic patients who received trabectome-mediated ab interno
trabeculectomy (T) or combined phacoemulsification with trabectome (PT). Included were
patients with a diagnosis of glaucoma with or without a visually significant cataract who had at
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least 12 months of follow-up with no additional glaucoma surgery. The specific target IOP was
set on a case-by-case basis by the individual treating physician as the maximum IOP estimated
to prevent further nerve damage. Patients with secondary open angle glaucoma (pigmentary,
pseudoexfoliation, steroid-induced, and uveitic) were also included. Cases were excluded if
patients were followed for less than 12 months, diagnosed with neovascular glaucoma, or were
pseudophakic.
Indications for T consisted of IOP above target with worsening glaucoma on maximally tol-
erated topical therapy. Indications for PT were the same, or stable glaucoma with the desire to
reduce the number of medications and a significant vision-impairing cataract with visual acuity
testing equal to or worse than at least 0.4 logMAR (20/50 Snellen).[5,13]
Visual field status of all patients was categorized as early, moderate, or advanced by individ-
ual glaucoma specialists based on the most recent Humphrey visual field exams (Zeiss, Jena,
Germany). All patients had a comprehensive slit lamp, gonioscopy, and dilated ophthalmos-
copy exam prior to surgery.
Statistics
Demographics were compared by the Mann-Whitney U test and chi-squared test for continu-
ous and categorical variables, respectively. To avoid eliminating data with missing values, mul-
tiple imputation was utilized. Missing values of the incomplete dataset were imputedm>1
times, thus creatingm completed datasets. Second, each of them completed datasets were inde-
pendently analyzed. Finally, the results from each of them analysis were pooled into a final
result. Missing data such as age, gender, and race were imputed by generating 5 similar but
non-identical datasets. Groups were then matched by utilizing Coarsened Exact Matching[12]
based on age, race, type of glaucoma (primary open angle glaucoma (POAG) and secondary
open angle glaucoma (SOAG)), baseline IOP, and number of preoperative glaucoma
medications.
Univariate linear regression was used to examine IOP reduction after surgery. Variables
that were statistically significant were included in the final multivariate regression model. A p-
value of less than 0.05 was considered statistically significant. Continuous variables were
expressed as mean±SD. All analyses was performed using R.[14]
Results
Baseline Characteristics
After applying exclusion criteria and matching, a total of 753 cases were included in the study
with 255 trabectome (T) cases and 498 phaco-trabectome (PT) cases (Fig 1). Primary open
angle glaucoma made up 81% and 86% of the treatment groups, respectively, with secondary
open angle glaucoma making up 19% and 14%, respectively. Baseline demographics of both
groups are shown in Table 1.
Age (p<0.01), race (p<0.01), baseline number of glaucoma medications (p<0.01), and
baseline IOP (p =<0.01) were found to be statistically different between groups. After Coars-
ened Exact Matching was applied, preoperative differences between the treatment groups were
minimized (Table 2). Age and race were now much more similar but differences still remained
significant (p<0.03).
Multiple Imputation and Coarsened Exact Matching
Missing data in each category were recorded. Glaucoma type and race had missing data among
both groups. T had an unknown glaucoma type in 1% and unknown race in 4% of patients. PT
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had an unknown glaucoma type in 2% and unknown race in 9% of patients. These missing val-
ues were imputed by generating 5 similar but non-identical completed datasets. Each com-
pleted dataset was then matched to minimize the baseline differences between treatment
groups.
Linear Regression Models
A linear regression of the multiple imputed, matched data was used to identify the magnitude
of various parameters on the IOP lowering effect of surgery. Univariate linear regression was
first performed (Table 3) using the variables age, race, phacoemulsification, SOAG (secondary
open angle glaucoma), baseline IOP, and number of medications at baseline.
Of these, all except race were found to be statistically significant and were included in the
final multivariate regression model (Table 4). Age, SOAG, and baseline IOP were found to be
statistically significant in both models (p<0.03, p<0.01, and p<0.01, respectively).
When all variables except for age were kept constant, there was an additional mean IOP
reduction of 0.05±0.01 mmHg conferred for every one unit increment in age. Similarly, SOAG
patients had a significant IOP reduction of 1.21±0.38 mmHg more than POAG patients.
Finally, every 1 mmHg increment in baseline IOP correlated to an additional IOP reduction of
Fig 1. Trabectome Surgeries. Flow chart with patient assignment to trabectome and phaco-trabectome groups with stratification by glaucoma type (IOP,
intraocular pressure; POAG, primary open angle glaucoma; SOAG, secondary open angle glaucoma).
doi:10.1371/journal.pone.0149384.g001
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0.80±0.02 mmHg. Principally, phacoemulsification was not found to be a statistically signifi-
cant factor (p0.05) in IOP outcomes between patients who underwent T and PT (Fig 2). Tra-
bectome-only patients had a 21% reduction in IOP to 15.9±3.5 mmHg (p<0.01) at 12 months
postoperatively while phaco-trabectome patients underwent an 18% reduction to 15.5±3.6
mmHg (p<0.01). Number of medications also significantly decreased (p<0.01) in both groups
to 1.9±1.3 (19% reduction) and 1.7±1.3 (24% reduction), respectively.
Scattergrams were generated to compare baseline IOP to IOP at 1 month and 12 months
between the T and PT cohorts (Fig 3). The black line indicates equal pre- and postoperative
IOP and eyes with a successfully lowered IOP would be expected below this line. Most eyes had
a postoperative IOP at the visit shown that was lower than the preoperative IOP. The red line is
a linear fit of pre- and postoperative IOPs.
Discussion
Using Coarsened Exact Matching, we found that phacoemulsification does not make a signifi-
cant difference in postoperative IOP when combined with trabectome surgery. Both groups
achieved a substantial reduction in IOP and number of medications. Hence, no additional IOP
reduction should be expected from combining phacoemulsification with trabectome surgery
when compared to a patient with similar baseline characteristics who received trabectome sur-
gery alone and remains phakic. This holds true despite the mixed indication in PT because the
medications were reduced equally in both T and PT. The indication in PT consisted of a visu-
ally significant cataract plus uncontrolled glaucoma or a visually significant cataract and the
desire to reduce medications in glaucoma that is otherwise controlled.
The raw data age differences between the T and PT group are consistent with the increased
incidence of cataracts with age.[15] Race, baseline IOP, and number of medications at baseline
Table 1. Raw Demographics. Demographics for Trabectome and Phaco-Trabectome show significant differences (p<0.05) for age, race, baseline IOP,
and baseline number of medications in the unmatched data.
Trabectome (n = 445) Phaco-Trabectome (n = 642) p-value
Age <0.01*
Mean±SD 63±15 73±9
Range (18, 96) (27, 94)
Type 0.15
Angle closure 4 (1%) 10 (2%)
POAG 324 (73%) 486 (76%)
SOAG 111 (25%) 130 (20%)
Race <0.01*
African American 34 (8%) 29 (5%)
Asian 119 (27%) 206 (32%)
Caucasian 216 (49%) 328 (51%)
Other 52 (12%) 20 (3%)
Baseline IOP <0.01*
Mean±SD 24.7±8.0 20.7±6.4
Range (10, 56) (10, 59)
Baseline # of Meds <0.01*
Mean±SD 2.8±1.4 2.3±1.2
Range (0, 7) (0, 5)
*The means are not weighted
doi:10.1371/journal.pone.0149384.t001
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were also significantly different in both cohorts and may represent glaucomas with a more
aggressive phenotype. After applying multiple imputation and Coarsened Exact Matching,
missing data was filled in as to not distort any relationships contained in the data while
enabling the inclusion of all observed data.[16] The differences in the groups were minimized
and allowed for a statistically valid comparison with linear regression. Earlier studies had
Table 3. Univariate Regression Results. Age, phacoemulsification, SOAG, baseline IOP, and baseline
number of medications were statistically significant (p<0.05).
Coefﬁcient Std. Error p-value
Phaco -1.75 0.5 <0.01*
Age 0.06 0.03 0.03*
Race
Asian 0.94 1.22 0.44
Caucasian 0.28 1.16 0.81
Other 3.24 1.91 0.09
SOAG 5.03 0.61 <0.01*
Baseline IOP 0.82 0.02 <0.01*
Baseline Rx 0.59 0.21 0.01*
*The means are not weighted
doi:10.1371/journal.pone.0149384.t003
Table 2. Matched Demographics. Matched data for the Trabectome and Phaco-Trabectome groups were highly similar.
Trabectome (n = 255) Phaco-Trabectome (n = 498) p-value
Age <0.01*
Mean±SD 69±11 72±9
Range (31, 95) (36, 93)
Type 0.06
Angle closure 0 (0%) 0 (0%)
POAG 206 (81%) 430 (86%)
SOAG 49 (19%) 68 (14%)
Pigmentary 13 13
Pseudoexfoliation 28 45
Steroid-induced 2 3
Uveitic 1 0
Unspeciﬁed 5 7
Race 0.03*
African American 13 (5%) 23 (5%)
Asian 68 (27%) 159 (32%)
Caucasian 162 (64%) 309 (62%)
Other 12 (5%) 7 (1%)
Baseline IOP <0.01*
Mean±SD 21.7±7.0 19.7±5.8
Range (10, 56) (10, 59)
Baseline # of Meds 0.05
Mean±SD 2.4±1.2 2.3±1.1
Range (0, 5) (0, 5)
*The means are not weighted
doi:10.1371/journal.pone.0149384.t002
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assumed that IOP reduction after trabectome surgery were independent of preoperative IOP
[10,17] and limited by episcleral venous pressure. This data suggests that elements downstream
of the TM contribute to the outflow resistance. This is consistent with results of excimer laser
ablation towards Schlemm’s canal from ab externo that found that a significant reduction
closer to the outer wall of Schlemm’s canal.[18]
Our results indicate that the IOP reduction around 1.5 to 3 mmHg seen after phacoemulsifi-
cation[2–4] is likely mediated by the TM. The partial bypassing of TM when using microstents
[7] compared to the more extensive TM removal[5] may make such an effect of phacoemulsifi-
cation on TMmore noticeable. Although a recent study has suggested that phacoemulsification
and intraocular lens implantation alone may be effective in decreasing IOP in glaucomatous
eyes,[19] this effect is often unreliable.[20] In contrast, trabectome-mediated ab interno trabe-
culectomy in our study achieved a profound IOP reduction already on day 1 and week 1
Table 4. Multivariate Linear Regression. Results for patient parameters that were found to be statistically
significant (p<0.05) in univariate linear regression.
Coefﬁcient Std. Error p-value
Intercept -14.78 1.18 <0.01*
Phaco -0.21 0.28 0.46
Age 0.05 0.01 <0.01*
SOAG 1.21 0.38 <0.01*
Baseline IOP 0.8 0.02 <0.01*
Baseline # of Meds -0.07 0.12 0.54
*The means are not weighted
doi:10.1371/journal.pone.0149384.t004
Fig 2. IOP and Medication Plots. IOP outcomes plot (left) demonstrates statistically significant (p<0.01) reductions in both groups (T: 21%, PT: 18%) at 12
months postoperatively. The Number of Medications plot (right) also demonstrates significant (p<0.01) decreased by 19% and 17% in each group,
respectively.
doi:10.1371/journal.pone.0149384.g002
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without any of the dangerous IOP elevations that can be seen in eyes with glaucoma undergo-
ing cataract surgery.[21] Thus, unlike studies that have shown synergistic IOP reduction when
combining a microbypass stent implantation with cataract removal,[8,22,23] the results here
suggest that adding phacoemulsification to trabectome surgery in hopes of further reducing
Fig 3. Intraocular Pressure Scattergrams. Scattergrams demonstrating IOP outcomes in comparison to baseline values among the Trabectome and
Phaco-Trabectome cohorts at the 1 and 12 month postoperative visits (red line = linear fit). Circles below the black dividing line are eyes with a postoperative
IOP that was lower than the preoperative IOP at that visit.
doi:10.1371/journal.pone.0149384.g003
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pressure may not provide these additional benefits. It may be more cost effective and safer to
only focus on TM ablation in patients without a visually significant cataract.
Limitations of this study are inherent to the observational nature compared to randomized
controlled trials. However, the coarsened exact matching (CEM) used here and multiple impu-
tation avoids discarding valid data. Although observational data is easy to collect compared to
randomized experiments, the mechanism of treatment assignment and other aspects of data
generation are often ambiguous and difficult to control. CEM is a newer form of automatic,
nonparametric matching to control the confounding influence of pretreatment control vari-
ables by achieving an acceptable balance between treated and control groups. CEM belongs to
the class of Monotonic Imbalance Bounding (MIB) that requires no assumptions about the
data generation process.[12]
In conclusion, we use coarsened exact matching to achieve a balanced comparison between
two unequal treatment groups, trabectome-mediated ab interno trabeculectomy combined
with phacoemulsification and trabectome-mediated ab interno trabeculectomy in phakic
patients. We find that phacoemulsification does not contribute significantly to IOP reduction
in these patients.
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